GCM
TMO icon

Graham Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Graham Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$438K Buy
+891
New +$484K 0.01% 680
2025
Q4 		– Sell
-2,290
Closed -$1.11M – 1581
2025
Q3 		$1.11M Sell
2,290
-2,353
-51% -$1.1M 0.02% 352
2025
Q2 		$1.88M Buy
4,643
+803
+21% +$336K 0.03% 377
2025
Q1 		$1.91M Buy
3,840
+2,885
+302% +$1.56M 0.03% 339
2024
Q4 		$497K Sell
955
-4,306
-82% -$2.37M 0.01% 740
2024
Q3 		$3.25M Sell
5,261
-22,388
-81% -$13.3M 0.06% 180
2024
Q2 		$15.3M Buy
27,649
+25,119
+993% +$14.4M 0.33% 33
2024
Q1 		$1.47M Buy
2,530
+1,266
+100% +$710K 0.03% 315
2023
Q4 		$671K Buy
1,264
+212
+20% +$103K 0.01% 499
2023
Q3 		$532K Sell
1,052
-550
-34% -$293K 0.01% 543
2023
Q2 		$836K Sell
1,602
-1,548
-49% -$835K 0.02% 414
2023
Q1 		$1.82M Sell
3,150
-2,119
-40% -$1.19M 0.06% 284
2022
Q4 		$2.9M Buy
5,269
+562
+12% +$298K 0.09% 157
2022
Q3 		$2.39M Sell
4,707
-3,734
-44% -$2.09M 0.09% 175
2022
Q2 		$4.58M Buy
8,441
+5,479
+185% +$3.02M 0.19% 65
2022
Q1 		$1.75M Buy
+2,962
New +$1.7M 0.06% 157

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Graham Capital Management's TMO Position: Q1 2026 in Review

Graham Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 891 shares worth $438K. The stake represents 0.01% of the portfolio and ranks #680 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in TMO as recently as Q3 2025.

Graham Capital Management first reported a position in TMO in Q1 2022 and has held it in 16 quarters since. The position peaked at $15.3M in Q2 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Graham Capital Management held 891 shares of Thermo Fisher Scientific worth $438K as of Q1 2026.
  • Thermo Fisher Scientific was a new Graham Capital Management position in Q1 2026.
  • Thermo Fisher Scientific made up 0.01% of Graham Capital Management's portfolio in Q1 2026, its #680 holding.
  • Graham Capital Management first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 16 quarters since.
  • Graham Capital Management's Thermo Fisher Scientific position peaked at $15.3M in Q2 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.